It's a green thing.

Martha Stewart is bringing her brand cache to cannabis. The lifestyle empress is partnering with Canopy Growth ($CGC), the Canadian pot grower and distributor, to help develop CBD and hemp-infused products for humans and animals, the company announced in a statement.

The partnership marks another step in the mainstreaming of marijuana, which is now legal for recreational use in Canada, where Canopy is based, and in a handful of U.S. states. CBD, the non-psychoactive cannabanoid, got a boost in the U.S. when President Trump signed the Farm Bill, legalizing hemp.

Stewart said in a statement that she is "delighted to establish this partnership with Canopy Growth and share with them the knowledge I have gained after years of experience in the subject of living."

Canopy said Stewart will first work on a line of CBD-infused products for pets. The company is currently in clinical trials on cannabis compounds meant to treat anxiety in animals.

Stewart will be in good company. Canopy, through a subsidiary, already has a partnership with Snoop Dogg who co-hosts a cooking show with Stewart on VH1.

By lending her name to Canopy's brand, Stewart is helping to further legitimize a red-hot industry that still faces hurdles in widespread acceptance in the U.S.

“As soon as you hear the name Martha, you know exactly who we’re talking about,” Canopy CEO Bruce Linton said in a statement.

Marijuana remains a schedule 1 drug at the federal level, though legalization at the state level continues to spread. Public sentiment has also changed: six in 10 Americans now say pot should be legalized for recreational use, according to Pew.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More